Koninklijke Philips (PHG) Income towards Parent Company (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Income towards Parent Company came in at $176.8 million in Q1 2026, up 121.14% year-on-year from $79.9 million in Q1 2025, and down 61.55% quarter-over-quarter from $459.8 million in Q4 2025.
Koninklijke Philips (PHG) Income towards Parent Company (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income towards Parent Company history runs 18 years deep, the most recent figure standing at $176.8 million for Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 121.14% year-over-year to $176.8 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 678.04% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 238.88% from the prior year.
- Income towards Parent Company slipped to $176.8 million in Q1 2026 per PHG's latest filing, from $459.8 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $485.7 million in Q2 2024 and bottomed at -$1.5 billion in Q3 2022.
- The 5-year median for Income towards Parent Company is -$108.1 million (2022), against an average of -$186.8 million.
- Across the five-year window, Income towards Parent Company tumbled 647.46% in 2022 and jumped 519.46% in 2024, its largest moves.
- Year by year, Income towards Parent Company stood at -$108.1 million in 2022, then slumped by 363.62% to -$501.4 million in 2023, then increased by 28.82% to -$356.9 million in 2024, then surged by 228.83% to $459.8 million in 2025, then tumbled by 61.55% to $176.8 million in 2026.
- Per Business Quant, the three latest PHG Income towards Parent Company figures stand at $176.8 million (Q1 2026), $459.8 million (Q4 2025), and $215.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176.78 Mn |
| Dec 31, 2025 | 459.80 Mn |
| Sep 30, 2025 | 215.11 Mn |
| Jun 30, 2025 | 271.67 Mn |
| Mar 31, 2025 | 79.94 Mn |
| Dec 31, 2024 | -356.91 Mn |
| Sep 30, 2024 | -403.05 Mn |
| Jun 30, 2024 | 485.68 Mn |
| Mar 31, 2024 | -1.09 Bn |
| Dec 31, 2023 | -501.39 Mn |
| Sep 30, 2023 | 95.80 Mn |
| Jun 30, 2023 | 78.40 Mn |
| Mar 31, 2023 | -713.77 Mn |
| Dec 31, 2022 | -108.15 Mn |
| Sep 30, 2022 | -1.52 Bn |
| Jun 30, 2022 | -184.60 Mn |
| Mar 31, 2022 | -169.47 Mn |
| Dec 31, 2021 | 3.80 Bn |
| Sep 30, 2021 | 512.99 Mn |
| Jun 30, 2021 | 33.72 Mn |